Eculizumab and ravulizumab clinical trial and real-world pharmacovigilance of meningococcal infections across indications

• Cynthia Carrillo Infante ,

  Contributed equally to this work with: Cynthia Carrillo Infante, Arshad Mujeebuddin

  Roles Conceptualization, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Global Patient Safety, Alexion, AstraZeneca Rare Disease, Boston, Massachusetts, United States of America

  ⨯
• Arshad Mujeebuddin

  Contributed equally to this work with: Cynthia Carrillo Infante, Arshad Mujeebuddin

  Roles Conceptualization, Methodology, Writing – original draft, Writing – review & editing

  * E-mail: Arshad.Mujeebuddin@alexion.com

  Affiliation Global Patient Safety, Alexion, AstraZeneca Rare Disease, Boston, Massachusetts, United States of America

  https://orcid.org/0000-0002-4752-7016

  ⨯